The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Interpreting clinically significant changes in patient‐reported outcomes
Open accessAbstract
BACKGROUND.: The goal of this study was to determine what magnitude of change in a patient‐reported outcome score is clinically meaningful, so a clinicians' guide may be provided for estimating the minimal important difference (MID) when empiric estimates are not available. METHODS.: Consecutive laryngeal cancer patients (n = 98) rated their quality of life (QOL) relative to other patients. These comparisons were contrasted with arithmetic differences in scores on the Functional Assessment of Cancer Therapy‐Head and Neck (FACT‐H&N) scale, Functional Assessment of Cancer Therapy‐General (FACT‐G) scale, 2 utility measures (the time tradeoff [TTO] and Daily Active Time Exchange [DATE]), and performance status (Karnofsky) scores. RESULTS.: The FACT‐H&N score needed to differ by 4% for average patients to rate themselves as “a little bit better” relative to other patients (95% CI, 1%–8%) and by 9% to rate themselves as “a little bit worse” relative to others (95% CI, 4%–13%). The corresponding values for other measures were FACT‐G 4% (1%–7%) and 8% (95% CI, 5%–11%); TTO 5% (95% CI, 0%–11%) and 6% (95% CI, 0%–10%); DATE 5% (95%CI, 2%–9%) and 14% (95% CI, 0%–5%); Karnofsky 4% (95% CI, 1%–6%) and 10% (95% CI, 7%–13%). In each case, the minimal important difference (MID) was about 5% to 10% of the instrument range. CONCLUSIONS.: One rule of thumb for interpreting a difference in QOL scores is a benchmark of about 10% of the instrument range. Patients appear to be more sensitive to favorable differences, so an improvement of 5% may be meaningful. This simple benchmark may be useful as a rough guide to meaningful change. Cancer 2007. © 2007 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Statistical Power Analysis for the Behavioral Sciences
Cohen, J. (2013) · doi:10.4324/9780203771587 · Cited by 25,373
Jaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000062554.74615.4c · Cited by 4,700
Interpreting the significance of changes in health-related quality-of-life scores.
Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.139 · Cited by 2,961
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
Determining a minimal important change in a disease-specific quality of life questionnaire
JUNIPER, E. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90036-1 · Cited by 1,824
Karnofsky performance status revisited: reliability, validity, and guidelines.
Schag, C. C., Heinrich, R. L., & Ganz, P. A. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.3.187 · Cited by 1,517
Walters, S. J., & Brazier, J. E. (2005) · Quality of Life Research · doi:10.1007/s11136-004-7713-0 · Cited by 1,341
Defining clinically meaningful change in health-related quality of life
Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00044-1 · Cited by 1,332
Cited by
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Kelly, R. J., Ajani, J. A., Kuzdzal, J., Zander, T., Van Cutsem, E., Piessen, G., Mendez, G., Feliciano, J., Motoyama, S., Lièvre, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032125 · Cited by 1,827
Bakitas, M., Lyons, K. D., Hegel, M. T., Balan, S., Brokaw, F. C., Seville, J., Hull, J. G., Li, Z., Tosteson, T. D., Byock, I. R., et al. (2009) · JAMA · doi:10.1001/jama.2009.1198 · Cited by 1,726
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
Doki, Y., Ajani, J. A., Kato, K., Xu, J., Wyrwicz, L., Motoyama, S., Ogata, T., Kawakami, H., Hsu, C.-H., Adenis, A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2111380 · Cited by 1,230
Kavalieratos, D., Corbelli, J., Zhang, D., Dionne-Odom, J. N., Ernecoff, N. C., Hanmer, J., Hoydich, Z. P., Ikejiani, D. Z., Klein-Fedyshin, M., Zimmermann, C., et al. (2016) · JAMA · doi:10.1001/jama.2016.16840 · Cited by 1,121
Myles, P. S., Myles, D. B., Galagher, W., Boyd, D., Chew, C., MacDonald, N., & Dennis, A. (2017) · British Journal of Anaesthesia · doi:10.1093/bja/aew466 · Cited by 1,017
A point of minimal important difference (MID): a critique of terminology and methods
King, M. T. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.9 · Cited by 646
Cocks, K., King, M. T., Velikova, G., de Castro, G., Martyn St-James, M., Fayers, P. M., & Brown, J. M. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.02.059 · Cited by 552
Berenson, J., Pflugmacher, R., Jarzem, P., Zonder, J., Schechtman, K., Tillman, J. B., Bastian, L., Ashraf, T., & Vrionis, F. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70008-0 · Cited by 524
Minimal Clinically Important Difference for Three Quality of Recovery Scales
Myles, P. S., Myles, D. B., Galagher, W., Chew, C., MacDonald, N., & Dennis, A. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001158 · Cited by 506
Clinimetrics Corner: The Minimal Clinically Important Change Score (MCID): A Necessary Pretense
Cook, C. E. (2008) · Journal of Manual & Manipulative Therapy · doi:10.1179/jmt.2008.16.4.82e · Cited by 465
Estimating Minimal Clinically Important Differences of Upper-Extremity Measures Early After Stroke
Lang, C. E., Edwards, D. F., Birkenmeier, R. L., & Dromerick, A. W. (2008) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2008.02.022 · Cited by 405
Rischin, D., Peters, L. J., O'Sullivan, B., Giralt, J., Fisher, R., Yuen, K., Trotti, A., Bernier, J., Bourhis, J., Ringash, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4449 · Cited by 380
Self-citationSiva, S., Bressel, M., Murphy, D. G., Shaw, M., Chander, S., Violet, J., Tai, K. H., Udovicich, C., Lim, A., Selbie, L., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.06.004 · Cited by 322
Chuasuwan, A., Pooripussarakul, S., Thakkinstian, A., Ingsathit, A., & Pattanaprateep, O. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01449-2 · Cited by 314
Chen, T. Y.-T., Wiltink, L. M., Nout, R. A., Meershoek-Klein Kranenbarg, E., Laurberg, S., Marijnen, C. A. M., & van de Velde, C. J. H. (2015) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2014.12.007 · Cited by 313
Honig, H., Antonini, A., Martinez‐Martin, P., Forgacs, I., Faye, G. C., Fox, T., Fox, K., Mancini, F., Canesi, M., Odin, P., et al. (2009) · Movement Disorders · doi:10.1002/mds.22596 · Cited by 274
Nout, R. A., Putter, H., Jürgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C. H. W., van der Steen-Banasik, E. M., Mens, J. W. M., Slot, A., Stenfert Kroese, M. C., van Bunningen, B. N. F. M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.2424 · Cited by 273
Cook, J., Hislop, J., Adewuyi, T., Harrild, K., Altman, D., Ramsay, C., Fraser, C., Buckley, B., Fayers, P., Harvey, I., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18280 · Cited by 194
Maringwa, J., Quinten, C., King, M., Ringash, J., Osoba, D., Coens, C., Martinelli, F., Reeve, B. B., Gotay, C., Greimel, E., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq726 · Cited by 161
Self-citationKernick, L. A., Hogg, K. J., Millerick, Y., Murtagh, F. E. M., Djahit, A., & Johnson, M. (2018) · Palliative Medicine · doi:10.1177/0269216318801162 · Cited by 68
Metadata
- Authors
- Ringash, J., O'Sullivan, B., Bezjak, A., & Redelmeier, D. A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2007-06-15
- Volume
- 110
- Issue
- 1
- Pages
- 196-202
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2000657166
- Cited by
- 305
- References
- 31
- FWCI
- 25.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.